Targeting the FGFR pathway in androgen receptor negative castration resistant prostate cancer

被引：1
|
作者：
Morrissey, Colm
Corey, Eva
Brown, Lisha
Coleman, Ilsa
Nguyen, Holly
Schweizer, Michael
Nelson, Peter
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2076
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2076
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A Road Map to Comprehensive Androgen Receptor Axis Targeting for Castration-Resistant Prostate Cancer
    Mitsiades, Nicholas
    CANCER RESEARCH, 2013, 73 (15) : 4599 - 4605
  • [32] An orally bioavailable degrader targeting androgen receptor and the splice variant in castration resistant prostate cancer
    Hung, Chiu-Lien
    Wang, Ling-Yu
    Fu, Chih-Wei
    Hsu, Hung-Chih
    Kung, Hsin-Jien
    CANCER RESEARCH, 2023, 83 (08)
  • [33] Androgen Receptor Antagonists in Castration-Resistant Prostate Cancer
    Rathkopf, Dana
    Scher, Howard I.
    CANCER JOURNAL, 2013, 19 (01): : 43 - 49
  • [34] Mechanisms of acquired resistance to androgen receptor targeting drugs in castration-resistant prostate cancer
    Chism, David D.
    De Silva, Dinuka
    Whang, Young E.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (11) : 1369 - 1378
  • [35] Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer
    Ban, Fuqiang
    Leblanc, Eric
    Cavga, Ayse Derya
    Huang, Chia-Chi Flora
    Flory, Mark R.
    Zhang, Fan
    Chang, Matthew E. K.
    Morin, Helene
    Lallous, Nada
    Singh, Kriti
    Gleave, Martin E.
    Mohammed, Hisham
    Rennie, Paul S.
    Lack, Nathan A.
    Cherkasov, Artem
    CANCERS, 2021, 13 (14)
  • [36] Targeting androgen receptor and the variants by an orally bioavailable Proteolysis Targeting Chimeras compound in castration resistant prostate cancer
    Hung, Chiu-Lien
    Liu, Hao-Hsuan
    Fu, Chih-Wei
    Yeh, Hsun-Hao
    Hu, Tsan-Lin
    Kuo, Zong-Keng
    Lin, Yu-Chin
    Jhang, Mei-Ru
    Hwang, Chrong-Shiong
    Hsu, Hung-Chih
    Kung, Hsing-Jien
    Wang, Ling-Yu
    EBIOMEDICINE, 2023, 90
  • [37] Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
    Menssouri, Naoual
    Poiraudeau, Loic
    Helissey, Carole
    Bigot, Ludovic
    Sabio, Jonathan
    Ibrahim, Tony
    Pobel, Cedric
    Nicotra, Claudio
    Ngo-Camus, Maud
    Lacroix, Ludovic
    Rouleau, Etienne
    Tselikas, Lambros
    Chauchereau, Anne
    Blanc-Durand, Felix
    Bernard-Tessier, Alice
    Patrikidou, Anna
    Naoun, Natacha
    Flippot, Ronan
    Colomba, Emeline
    Fuerea, Alina
    Albiges, Laurence
    Lavaud, Pernelle
    van de Wiel, Paul
    den Biezen, Eveline
    Wesseling-Rozendaal, Yvonne
    Ponce, Santiago
    Michiels, Stefan
    Massard, Christophe
    Gautheret, Daniel
    Barlesi, Fabrice
    Andre, Fabrice
    Besse, Benjamin
    Scoazec, Jean-Yves
    Friboulet, Luc
    Fizazi, Karim
    Loriot, Yohann
    CLINICAL CANCER RESEARCH, 2023, 29 (21) : 4504 - 4517
  • [38] Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis
    X Yuan
    C Cai
    S Chen
    S Chen
    Z Yu
    S P Balk
    Oncogene, 2014, 33 : 2815 - 2825
  • [39] Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis
    Yuan, X.
    Cai, C.
    Chen, S.
    Chen, S.
    Yu, Z.
    Balk, S. P. p
    ONCOGENE, 2014, 33 (22) : 2815 - 2825
  • [40] Progression of Castration-Resistant Prostate Cancer After Docetaxel and Androgen Receptor-Targeting Agent
    Gonzalez-Ochoa, Eduardo
    Verduzco-Aguirre, Haydee
    Crawford, E. David
    Bourlon, Maria T.
    ONCOLOGY-NEW YORK, 2020, 34 (04): : 125 - 129
12345